Meghmani Organics · forward-looking guidance across the available source record.
Guidance tracker
Management expects agrochemical segment margins to normalize to industry average of 15-17% as tariff-related uncertainties ease and formulation mix improves (currently 40% formulations, targeting higher).
Operational improvements including renewable energy (3.5 MW), process automation, and reduced manpower costs expected to improve pigment EBITDA margins to 8-9% starting Q1 FY27.
Plant restart planned by mid-year once sulfuric acid prices normalize (expected June 2026) and anti-dumping duty is reimposed. DGTR work completed; finance ministry order expected in coming months.
Routine maintenance and debottlenecking only; no major expansion capex planned as company focuses on deleveraging (₹128 cr debt repaid YTD) and improving returns on existing assets.
Management expects better revenue and profitability in FY27 compared to FY26 based on improving demand conditions and stabilization of cost pressures.
Long-term EBITDA margin guidance of 15-17% maintained for crop protection segment; management expects to achieve this range in FY27 as cost pass-through normalizes.
Pigment segment top-line expected in Rs 500-600 crore range with significantly improved profitability versus FY26's 3.3% EBITDA margin through cost optimization and better price realization.
No significant expansion capex planned for FY27; only routine maintenance capex of Rs 35-40 crore expected.